Back

PDS Biotechnology shares surge 50.11% after $11.3 million financing close

Verifying
  • PDS Biotechnology completed the initial closing of financing led by Nant Capital.
  • $11.3 million in gross proceeds came from the first tranche.
  • An $11 million milestone tranche depends on a Phase 3 filing for colorectal cancer.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.